Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro,

Gustavo Milson Fabrício-Silva1, Bruno Silva Poschetzky2, Renata de Mello Perez2

  • 1Histocompatibility and Cryopreservation Laboratory, Rio de Janeiro State University, Rio de Janeiro, Brazil.

Insights

Interleukin-28B (IL-28B) gene variations are linked to spontaneous hepatitis C virus (HCV) clearance and treatment success in Brazilians. The IL-6 (-174) C allele may also aid spontaneous recovery and reduce liver inflammation.

Area of Science:

  • Immunogenetics
  • Hepatology
  • Virology

Background:

  • Host immune response significantly impacts Hepatitis C Virus (HCV) infection outcomes and disease progression.
  • Investigating cytokine gene polymorphisms offers insights into susceptibility to persistent HCV infection versus spontaneous viral clearance.

Purpose of the Study:

  • To explore cytokine gene polymorphisms as potential markers for HCV infection susceptibility or spontaneous clearance.
  • To analyze these genetic factors in a Brazilian population from Rio de Janeiro.

Main Methods:

  • Genotyping of cytokine polymorphisms including TNF-alpha, TGF-beta 1, IL-10, IL-6, and IFN-gamma using PCR.
  • Assessing IL-28B polymorphisms (rs12979860, rs12980275, rs8099917) via real-time PCR.
  • Study included 245 chronic hepatitis C patients, 41 spontaneous recovery patients, and 189 healthy controls.

Main Results:

  • IL-28B rs12979860 CC and rs12980275 AA genotypes strongly correlated with spontaneous HCV recovery and treatment response.
  • The IL-6 (-174) C allele showed a protective association against chronic hepatitis C (CHC) and was more prevalent in spontaneous recovery patients.
  • Multivariate analysis identified male sex, specific IL-28B genotypes (CT, TT), and TGF-beta 1 codon 10 TC genotype as factors associated with CHC.

Conclusions:

  • IL-28B polymorphisms are key determinants of spontaneous HCV clearance and therapeutic response in the studied Brazilian cohort.
  • The IL-6 (-174) C allele appears to play a role in spontaneous recovery and may contribute to reduced liver inflammation.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
37
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
24
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.8K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
158
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109